Repurposing loperamide to target glioma, metabolic reprogramming, liquid biopsies.
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on February 01, 2023 03:22 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 337510355 series 3382249
المحتوى مقدم من Andrew Scarborough. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Andrew Scarborough أو شريك منصة البودكاست الخاصة بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك ، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
In this episode, recorded just before the New Year, I discuss recent news in brain cancer research.
This includes:
How the drug loperamide (brand name Imodium), induces cell death in glioblastoma cell lines and if this could have promise for real, human applications.
Metabolic reprogramming via inhibition of a key cancer metabolite- D-2-Hydroxyglutarate (D-2-HG).
Developments of liquid biopsies for glioma.
21 حلقات
مشاركة
))
